Ally Biotech

As Benzinga Cannabis Capital Conference returns to Chicago this Sept 27-28 for its 17th edition, gathering top CEOs, investors and leaders in the marijuana industry, let's scroll through the latest leadership changes in the space. New Board Appointments Two Canadian cannabis and hemp-focused...

Ally Biotech announced the acquisition of the Chill Pill brand, a line of soft, soft gel caps and all of its assets, from Desert Medical Campus, in an all-cash transaction. Company president, Jim Mackowiak, said plans are underway to expand the Chill Pill line to include new products that are...